Prescribing Tirzepatide for OSA- Practical Implementation and Challenges

Description

Since the introduction of using tirzepatide for patients with obstructive sleep apnea, AASM members have been given details about the drugs but have been missing the practical application of prescribing it in-clinic. This webinar will aim to help sleep medicine clinicians better understand when and how to prescribe the recently approved obesity medication tirzepatide for patients with a diagnosis of obstructive sleep apnea.

Objectives

Upon completion of this activity, participants should be able to:

List the clinical indications and contraindications and compare to the FDA approval for prescribing tirzepatide for OSA.
Implement tirzepatide as combination therapy for OSA. Implement a framework for integrating obesity management into sleep medicine practice.
Identify administrative challenges in prescribing tirzepatide and suggest clinical practice workflows for decreasing rates of payor denials.
Recognize risks and liability associated with compound drugs marketed for obesity management and identify the role of the FDA in their production.

Summary

Availability:

On-Demand

Credit Offered:

No Credit Offered